Home
Search results “Renal cell cancer for patients”
Renal cell carcinoma - causes, symptoms, diagnosis, treatment, pathology
 
06:47
What is Renal Cell Carcinoma? It form from epithelial cells in the proximal convoluted tubule of the kidney. Find more videos at http://osms.it/more. Hundreds of thousands of current & future clinicians learn by Osmosis. We have unparalleled tools and materials to prepare you to succeed in school, on board exams, and as a future clinician. Sign up for a free trial at http://osms.it/more. Subscribe to our Youtube channel at http://osms.it/subscribe. Get early access to our upcoming video releases, practice questions, giveaways, and more when you follow us on social media: Facebook: http://osms.it/facebook Twitter: http://osms.it/twitter Instagram: http://osms.it/instagram Our Vision: Everyone who cares for someone will learn by Osmosis. Our Mission: To empower the world’s clinicians and caregivers with the best learning experience possible. Learn more here: http://osms.it/mission Medical disclaimer: Knowledge Diffusion Inc (DBA Osmosis) does not provide medical advice. Osmosis and the content available on Osmosis's properties (Osmosis.org, YouTube, and other channels) do not provide a diagnosis or other recommendation for treatment and are not a substitute for the professional judgment of a healthcare professional in diagnosis and treatment of any person or animal. The determination of the need for medical services and the types of healthcare to be provided to a patient are decisions that should be made only by a physician or other licensed health care provider. Always seek the advice of a physician or other qualified healthcare provider with any questions you have regarding a medical condition.
Views: 96820 Osmosis
Renal Cell Carcinoma - causes, symptoms and treatment
 
04:59
Renal cell carcinoma (RCC) is also called hypernephroma, renal adenocarcinoma, or renal or kidney cancer. It’s the most common kind of kidney cancer found in adults. The kidneys are organs in your body that help get rid of waste, while also regulating fluid balance. Subscribe my channel: https://www.youtube.com/channel/UCjPGXgOH-anpsvLMiw8NYdA Follow us: https://plus.google.com/u/0/b/118041852373056007310/118041852373056007310 https://web.facebook.com/Health-Tips-Page-1724798314435434/ https://twitter.com/?lang=en Other videos: https://www.youtube.com/watch?v=1HW0r0QGSvk https://www.youtube.com/watch?v=iMuesRzj22M https://www.youtube.com/watch?v=hKNqwbfxzyc https://www.youtube.com/watch?v=9KySzN3unQU Symptoms of Renal cell carcinoma. Early on, renal cell carcinoma doesn’t usually cause any sign. As the disease gets more advance, you might have warning signs like: A lump on your side, belly, or lower back. Blood in your pee. Low back pain on one side. Losing weight for no clear reason. Lose of appetite. Fever. Feeling tired. Not enough red blood cells (anemia). Night sweats. High levels of calcium in your blood. High blood pressure. Causes of Renal cell carcinoma. The exact cause of renal cell carcinoma is not known. Scientist know that most kidney cancers start when something goes wrong in the genes in the kidney. No one can say for certain why that happens. Several factors can raise your chances of getting the disease, like: Smoking. Being very overweight. Taking a lot of pain medicine, like aspirin, ibuprofen, or acetaminophen, for a long time. Exposure to certain dyes, asbestos, cadmium (a metal), herbicides, and solvents. Some inherited conditions, especially von Hippel-Lindau disease. How Is Renal Cell Carcinoma Diagnosed? If your doctor suspects that you may have RCC, he will ask about your personal and family history. He will then do a physical exam. Findings that can indicate RCC include swelling or lumps in the abdomen, or, in men, enlarged veins in the scrotal sac. If RCC is suspected, your doctor will order a number of tests including: A complete blood count. A CT scan. Abdominal and kidney ultrasounds. Urine examination. A biopsy. Treatments for Renal Cell Carcinoma. There are five kinds of standard treatments for RCC. One or more may be used to treat your cancer. Surgery: Surgery can include different types of procedures. During a partial nephrectomy, part of the kidney is removed. During a nephrectomy, the entire kidney may be removed. Depending on how far the disease has spread, more extensive surgery may be needed to remove surrounding tissue, lymph nodes, and your adrenal gland. This is a radical nephrectomy. If both kidneys are removed, a dialysis or a transplant is necessary. Radiation: Radiation therapy involves using high-energy X-rays to kill cancer cells. The radiation can be given externally by a machine, or placed internally using seeds or wires. Chemotherapy: Chemotherapy uses drugs to kill cancer cells. It can be given orally or intravenously, depending on what medication is chosen. This allows the drugs to go through the bloodstream and reach cancer cells that may have spread to other parts of the body. Biologic therapy: Biologic therapy, also called immunotherapy, works with your immune system to attack the cancer. Enzymes or substances made by the body are used to defend your body against the cancer. Targeted therapy: Targeted therapy is a newer kind of cancer therapy. Drugs are used to attack certain cancer cells without damaging healthy cells. Some drugs work on blood vessels to prevent blood flow to the tumor, “starving” and shrinking it. Clinical trials: Clinical trials are another option for some patients with RCC. Clinical trials test new treatments to see if they are effective in treating the disease. During the trial you will be closely monitored, and you can leave the trial at any time. Talk with your treatment team to see if a clinical trial is a viable option for you. Like and share this video. Don't forget to Subscribe my channel for health updates.
Views: 5931 Health Tips
Renal Cell Carcinoma
 
56:59
(Visit: http://www.uctv.tv/) In the United States, there are over 60,000 new diagnoses and nearly 14,000 deaths from kidney cancer each year. Dr. Won Kim reviews the epidemiology of kidney cancer (including established risk factors), the biology and pathophysiology of kidney cancer, treatment options for localized disease, and the role of systemic therapy in the treatment of advanced, metastatic disease. He also discusses the current and future role of immunotherapy in kidney cancer. Recorded on 07/15/2014. Series: "UCSF Osher Center for Integrative Medicine presents Mini Medical School for the Public" [9/2014] [Health and Medicine] [Show ID: 28502]
Renal Cell Carcinoma for USMLE
 
19:57
Renal Cell Carcinoma Anatomy, Epidemiology, Etiology, Clinical Signs and Symptoms, Treatment and Management. Handwritten, full lecture for medical students taking USMLE. Renal Cell Carcinomas make up 90-95% of kidney neoplasms. ETIOLOGY of Renal Cell Carcinoma Smoking is the largest risk factor. Obesity and Hyppertension is a known risk factor for Renal Cell Carcinoma in Women. Occupational Exposure such as Trichloroethylene, Benzine, Herbicides, Vinyl Chloride. Drugs associated with Renal Cell Carcinoma (phenacitin). Long term dialysis increases the risk of cystic Diseases which increase risk of renal cell carcinoma. Von Hipel Lindau - Loss of 3p increases HIF which increases angiogenesis. Also increase risk of pheochromocytoma, pancreatic cysts/islet cell tumors, retinal angiomas, CNS hemangioblastomas. Hereditary Papillary Renal Carcinoma - MET Gene mutation of tyrosine kinase domain and will have bilateral multifocal papillary renal cell carcinoma. Burt-Hogg-Dube Syndrome - Bilateral Multifocal oncocytoma which has a better prognosis. Also may cause pulmonary and colonic tumors. CLINICAL SIGNS AND SYMPTOMS of Renal Cell Carcinoma. The three most common presenting signs and symptoms is flank pain, hematuria, flank mass. A large percentage of patients may be asymptomatic. Patients with renal cell carcinoma may also have wieght loss, varicocele, malaise, fever. Paraneoplastic syndromes are very common in renal cell carcinoma. Increase EPO may lead to polycythemia, Renin production may lead to hypetension. Finally may also have hypercalcemia, polyneuropathy. Shauffer Syndrome - Non-metastatic Hepatic Dysfunction and therefore it is important to monitor liver function, even if no metastasis has occurred. Metastasis to Lungs (45%), Soft tissue and Liver. Work Up for Renal Cell carcinoma Labs - Urinalysis, CBC, Electrolytes, Renal Profile, LFT (AST/ALT) and Serum Calcium. Imaging - CT scan is the imaging of choice and can identify the tumor and rule out cystic mass. Also allows visualtion of Lymph nodes, Renal Vein, IVC and helps rule out angiolipoma. For staging abdominal ;pelvic CT with or without contrast. Chest X-ray and Brain MRI. Histology Clear Cell Carcinoma - 75%, lipid/glycogen Chromphilic - Bilateral mulftifocal Chromophobic - Large polygonal Cells Oncocytoma - Rarely metastasize Collecting Tubules STAGING OF Renal Cell Carcinoma Stage 1 - Within the kidney and less than 7cm. Stage 2 - Within the kidney and greater than 7cm. Stage 3 - Invasion Renal Vein and Inferior Vena Cava or Adrenal Gland, but does not invade Gerota's Fascia Stage 4 - Extends below Gerota's Fascia, invade nearby lymph nodes and metastasis to organs. MANAGEMENT of Renal Cell Carcinoma Surgical Partial nephrectomy for stage 1 and sometimes stage 2 Radical Nephrectomy - remove complete removal of Gerota's fascia, Removal of kidney with adrenal gland, dissect enlarge lymph nodes. Palliative Nephrectomy - remove kidney to alleviate pain, polycythemia and hypertension. Adjuvant Treatment for Renal Cell Carcinoma Biologic Response Mediators - IL2 (activates T Cell and NK), IFN Molecular Targeting - Suritinib, Bevacizumab, Dazopomib, Temsirolimu, Sorafenib. Chemotherapy - 5 floururacil, Vinblastine, Paclitaxel, Caboplatin, Ifosfamide, Gemcitabine. Radiation - Renal Cell Carcinoma is not sensitive to radiation but the brain metastasize are sensitive. Renal Artery Embolization inject ethanol or gelatin sponge pledgets in artery feeding tumor to help kill off the tumor. Also done palliative for non-surgical patient.
Views: 19096 the study spot
Renal Cell Carcinoma Prognosis Life Expectancy and Survival Rates
 
05:24
Renal Cell Carcinoma Prognosis Life Expectancy and Survival Rates. What is renal cell carcinoma?. Kidney disease happens when growth cells shape in the kidneys. More than 90 percent of kidney growths are renal cell carcinomas (RCC), which begin in the tubules of the kidneys. Tubules are modest tubes in the kidneys that assistance channel squander items from the blood keeping in mind the end goal to make pee. The rest of the 10 percent of kidney tumors begin in the renal pelvis in the focal point of the kidney, which is the place pee gathers. In the United States, kidney tumor is the seventh most basic growth in men and the ninth most normal disease in ladies, as per the Cleveland Clinic. What builds your hazard?. Hazard factors for creating renal cell carcinoma include: *smoking. *hypertension. *obesity. hepatitis C. What are the main side effects?. One of the primary manifestations of kidney malignancy is the presence of blood in the pee. Furthermore, infrequently a protuberance can be felt in the mid-region. How is it analyzed?. To analyze kidney tumor, a specialist will play out a physical exam and request imaging tests, for example, *ultrasound. *CT examine. *MRI. Your specialist will arrange a urinalysis and other lab work on the off chance that they speculate malignancy or other kidney malady. On the off chance that the lab and imaging tests uncover a suspicious mass, your specialist will complete a biopsy to check for harmful cells. Beginning periods of kidney tumor. When kidney tumor is affirmed, your therapeutic group will decide the phase of the growth. The stage depends on how much or how little the malignancy has spread. *Stage 1 implies the growth is just in the kidney, and that the tumor is 7 centimeters in length or littler. *Stage 2 implies the growth is as yet contained to the kidney, however the tumor is bigger than 7 centimeters. At the point when kidney tumor metastasizes. Stages 3 and 4 show that the tumor has metastasized, or spread to different parts of the body. Kidney disease spreads through blood, lymph hubs, or by coordinate augmentation of the first carcinogenic tumor into adjacent tissue or structures. *Stage 3 implies the tumor is additionally present in a lymph hub close to the kidney, or in a principle kidney vein or greasy tissue around the kidney. *Stage 4 implies the malignancy has spread to another organ, or removed lymph hubs. Treatment alternatives. Treatment for kidney malignancy relies upon the phase of the tumor. In the event that the tumor is little and the patient is qualified for surgery, an incomplete nephrectomy might be conceivable. This task saves the kidney, yet evacuates the tumor and a portion of the encompassing tissue. A full nephrectomy, in which a whole influenced kidney is evacuated, might be vital in further developed cases. Now and again, where surgery isn't a choice, cryoablation might be an answer if the tumor is strong and in a contained region. Cryoablation is a methodology that includes the solidifying of tumor cells. Empowering prescription advancements. Prescription treatment is regularly utilized if the malignancy has spread. These medications help support the body's safe framework. There additionally have been empowering advancements with drugs that objective kidney growth cells, as indicated by the Cleveland Clinic. As per the American Cancer Society, there are seven focused on treatment medicines for kidney disease. Directed treatments are drugs that objective particular receptors or atoms along the disease cell development pathways that moderate or end malignancy development. Components influencing viewpoint. All Photos Licensed Under CC Source : www.pexels.com www.pixabay.com www.commons.wikimedia.org
Views: 6482 Beauty & Health Tips
How to treat and cure  Kidney cancer renal cell cancer
 
17:48
This video has how to treat Kidney cancer (renal cell cancer)-How to treat and cure Kidney cancer (renal cell cancer)
Views: 5106 Shelby Lopez
Clear Cell and Chromophobe Renal Cell Carcinoma
 
03:45
Histologic featues and facts about clear cell and chromophobe renal cell carcinomas
Views: 6083 UAMS Pathophysiology
Histopathology Kidney--Renal cell carcinoma
 
03:37
Histopathology Kidney--Renal cell carcinoma
Views: 19244 WashingtonDeceit
Kidney Cancer Survivor, Joelle's Story | City of Hope
 
02:48
To make an appointment at City of Hope, call 800-826-HOPE (4673) or to learn more information, visit http://www.cityofhope.org Joelle was shocked when she learned she had kidney cancer. Her doctor referred her to City of Hope, and Joelle knew she would be in good hands. After minimally invasive robotic surgery, Joelle is now cancer free. City of Hope is a leading research and treatment center for cancer, diabetes and other life-threatening diseases. Designated as a comprehensive cancer center, the highest recognition bestowed by the National Cancer Institute, City of Hope is also a founding member of the National Comprehensive Cancer Network, with research and treatment protocols that advance care throughout the nation. City of Hope's main hospital is located in Duarte, Calif., just northeast of Los Angeles, with clinics in Antelope Valley and South Pasadena. It is ranked as one of "America's Best Hospitals" in cancer by U.S.News & World Report. Founded in 1913, City of Hope is a pioneer in the fields of bone marrow transplantation and genetics. ############################## CONNECT WITH CITY OF HOPE http://www.facebook.com/cityofhope http://www.twitter.com/cityofhope http://breakthroughs.cityofhope.org http://thehelix.cityofhope.org http://www.pinterest.com/cityofhopepins http://www.flickr.com/cityofhope http://www.causes.com/cityofhope and more at http://www.cityofhope.org
Views: 6714 City of Hope
Treating Advanced Renal-Cell Carcinoma
 
02:13
Approximately 75% of patients with advanced renal-cell carcinoma have an intermediate or poor prognosis, with a low rate of response to standard treatment with sunitinib and a high rate of toxic effects. Full trial results: http://nej.md/2GaYWq9 Watch more Quick Take videos: http://nej.md/quick-take
Views: 2037 NEJMvideo
Stage 4 Renal Cell Carcinoma Metastasis, Survival Rates, and Treatment
 
04:52
Stage 4 Renal Cell Carcinoma Metastasis, Survival Rates, and Treatment. What Is Renal Cell Carcinoma?. Renal cell carcinoma (RCC), additionally called renal cell tumor or renal cell adenocarcinoma, is a typical kind of kidney growth. Around 90 percent of all kidney growths are renal cell carcinomas. RCC normally starts as a tumor developing in one of your kidney. It can likewise create in both kidneys. The ailment is more typical in men than ladies. How Can It Spread?. On the off chance that a malignant tumor is found in one of your kidneys, the typical treatment is to evacuate part or the majority of the influenced kidney surgically. On the off chance that the tumor is abandoned, it's more probable that the growth will spread to either your lymph hubs or different organs. The spread of growth is called metastasis. On account of RCC, the tumor can attack a huge vein driving out of the kidney. It can likewise spread to the lymph framework and different organs. The lungs are particularly helpless. TMN Staging and the Stages of Kidney Cancer. Kidney malignancy is depicted in stages created by the American Joint Committee on Cancer. The framework is also called the TMN framework. *The "T" alludes to the tumor. Specialists appoint a "T" with a number from one to three, in view of the size and development of the tumor. *An "N" depicts whether the disease has spread to a hub in the lymph framework. *The "M" implies the tumor has metastasized. Specialists likewise dole out RCC a phase in view of the measure of the tumor and the spread of the growth. There are four phases: *Stages 1 and 2 portray malignancies in which the tumor is still in the kidney. Stage 2 implies that the tumor is developing and is bigger than seven centimeters over. *Stages 3 and 4 mean the malignancy has spread either into a noteworthy vein, to lymph hubs, or to different organs. *Stage 4 is the most developed type of the malady. Stage 4 implies that the disease has metastasized to the lymph framework or different organs. Since the adrenal organ is appended to the kidney, the malignancy regularly spreads there first. Stage 4 kidney disease likewise implies that the malignancy may have spread into more than one lymph hub close to the kidney or somewhere else in the body. What's the Outlook?. Five-year survival rates for RCC depend on the level of patients who inhabit minimum five years with the malady after it's been analyzed. The American Cancer Society reports the accompanying five-year survival rates, as indicated by organize: *stage 1: 81 percent. *stage 2: 74 percent. *stage 3: 53 percent. *stage 4: 8 percent. What Are the Treatment Options?. The sort of treatment you get to a great extent relies upon the phase of your tumor. Stage 1 RCC might be treated with surgery. Be that as it may, when the disease has progressed to arrange 4, surgery is frequently impossible. In the event that the tumor and metastasis can be secluded, surgical expulsion of the malignant tissue may at present be conceivable. On the off chance that the malignancy has spread to the lungs, incomplete lung expulsion may dispose of the tumor. On the off chance that you have organize 4 RCC, your specialist will think about your general wellbeing to decide your qualification for significant surgery. In the event that surgery isn't a practical choice to treat arrange 4 RCC, different treatments may help. One approach is embolization, which is the hindering of blood stream to malignancy cells. In any case, there's a hazard that the substance that hinders the blood stream will likewise meddle with flow to solid cells. Another alternative is radiation treatment. This treatment utilizes high-vitality radiation to target growth cells. In any case, it's not typically effective when the malignancy has spread to numerous areas. Diagram: The most ideal approach to beat organize 4 RCC is to forcefully treat the disease before it gets the opportunity to arrange 4. In case you're in arrange 4 RCC, recall that distributed survival rates are midpoints. The key is to take after your specialist's recommendation, go to your arrangements, and take your medicines. Likewise, make a point to roll out whatever way of life improvements your specialist recommends. All Photos Licensed Under CC Source : www.pexels.com www.pixabay.com www.commons.wikimedia.org
Views: 5673 Beauty & Health Tips
Huge Kidney Cancer Removal..!! Open Surgery..!! Live Surgery..!!
 
08:08
Kidney cancer, also known as renal cancer, is a type of cancer that starts in the cells in the kidney. Types Of Kidney Cancer: Most Common types: 1) renal cell carcinoma 2) renal pelvis carcinoma Less Common Types: 1) Squamous cell carcinoma 2)Juxtaglomerular cell tumor (reninoma) 3)Angiomyolipoma 4)Bellini duct carcinoma 5)Clear-cell sarcoma of the kidney 6)Mesoblastic nephroma 7)Wilms' tumor, usually is reported in children under the age of 5 8)Mixed epithelial stromal tumor Treatment: Treatment for kidney cancer depends on the type and stage of the disease. Surgery is the most common treatment as kidney cancer does not often respond to chemotherapy and radiotherapy. Surgical complexity can be estimated by the RENAL Nephrometry Scoring System. If the cancer has not spread it will usually be removed by surgery. In some cases this involves removing the whole kidney however most tumors are amenable to partial removal to eradicate the tumor and preserve the remaining normal portion of the kidney. Surgery is not always possible – for example the patient may have other medical conditions that prevent it, or the cancer may have spread around the body and doctors may not be able to remove it. There is currently no evidence that body-wide medical therapy after surgery where there is no known residual disease, that is, adjuvant therapy, helps to improve survival in kidney cancer. If the cancer cannot be treated with surgery other techniques such as freezing the tumour or treating it with high temperatures may be used. However these are not yet used as standard treatments for kidney cancer. Other treatment options include biological therapies such as everolimus, torisel, nexavar, sutent, and axitinib, the use of immunotherapy including interferon and interleukin-2. Immunotherapy is successful in 10 to 15% of people. Sunitinib is the current standard of care in the adjuvant setting along with pazopanib; these treatments are often followed by everolimus, axitinib, and sorafenib. In the second line setting, nivolumab demonstrated an overall survival advantage in advanced clear renal cell carcinoma over everolimus in 2015 and was approved by the FDA. Cabozantinib also demonstrated an overall survival benefit over everolimus and was approved by the FDA as a second-line treatment in 2016. Lenvatinib in combination with everolimus was approved in 2016 for patients who have had exactly one prior line of angiogenic therapy. In Wilms' tumor, chemotherapy, radiotherapy and surgery are the accepted treatments, depending on the stage of the disease when it is diagnosed
Views: 10080 SDM
Renal Cell Cancer
 
07:02
Renal cell cancer is the most lethal of urologic cancers Bone metastases in patients with renal cell cancer (RCC) are associated with a high risk of skeletal complications. About 40% of patients with RCC develop bone metastases. RCC is the fourth most common metastatic tumor of the spine and the most common cancer to present as a neurologic deficit secondary to an undetected primary malignancy. Chemotherapy and hormone therapy are ineffective, making radiation and surgery the mainstays of treatment. Failure to respond to or relapse after radiotherapy is common (American Journal of Neuroradiology 22:997-1003 (5 2001) The median survival time with distant metastatic RCC is around 6 months, and few cases survive beyond 2 years. The incidence of spontaneous regression of metastatic renal cell cancer is thought to be less than 1% of all cases. It is reported that complete regression is even rarer than partial regression
Views: 318 Prashant Sawant
Kidney Cancer Stages
 
03:27
Click on http://stayhealthyvideos.com/kidneydisease to learn more about kidney health in general. Click on http://stayhealthyvideos.com/kidneydiet to get detailed information about a kidney healthy diet. Transcript: Kidney Cancer Stages Kidney cancer stage descriptions are a standard means of recognizing how far a case of kidney cancer has progressed. The doctor can use kidney cancer staging as a way of determining the best course of treatment for anyone who has cancer of the kidney. The stage basically reflects how much the cancer has spread. Is it present only in the kidney itself, or have some of the cells broken away and affected the lymph nodes or even other organs of the body? There are a variety of factors that medical professionals use to evaluate the kidney cancer stage. Once all these factors are evaluated, your doctor will assign a number from 1 through 4 to your case. Sometimes Roman numerals I, II, III, and IV will be used instead. This practice is more common with doctors than with the general public. Generally speaking, you can also calculate a patient's 5-year survival rate based on the kidney cancer stage once you know it. Every case is different, of course, but research through the years has shown that someone who has kidney cancer stage 1 is more likely to survive for a longer period of time than someone at stage 4. Here is a brief description of each kidney cancer stage. Stage 1 - The cancer area is less than 7 centimeters across, or approximately 2.8 inches. It is still localized, that is, completely inside the kidney. Stage 2 - The cancer has grown and exceeded 7 centimeters, or 2.8 inches. However, it is still located within the kidney and has not spread. Stage 3 - The cancer has become more dangerous because it has spread into the adrenal gland, or possibly a major vein in the area. At this stage it can also be found in no more than one lymph node. Stage 4 - Stage 4 is advanced kidney cancer and is at a very dangerous stage. Cancer cells have spread into more than one lymph node, or into some of the tissues that surround the kidney or even to a distant organ or part of the body. This process is known as metastasis. The stage 4 kidney cancer life expectancy for five years is quite low. The five-year survival rate is slightly less than one in ten. Another important way to describe the progression of kidney cancer is by assigning a grade to it. This grade is determined by the appearance of the cancer cells under the microscope. If the cells closely resemble normal kidney cells, a lower grade is assigned. The more abnormal they look, the higher the grade. This diagnosis is important because it will help your doctor evaluate how quickly the cancer is likely to spread. High grade cancers are more likely to spread quickly. In summary, kidney cancer stages give doctors a helpful tool they can use to decide on the best course of treatment for the disease. The main determinant for deciding which treatment is most likely to bring a positive outcome is whether the cancer has metastasized, meaning whether it spread away from the kidney or not.
Views: 43868 WS Westwood
Kidney Cancer Survival Rate
 
04:01
Click on http://stayhealthyvideos.com/kidneydisease to learn more about kidney health in general. Click on http://stayhealthyvideos.com/kidneydiet to get detailed information about a kidney healthy diet. Transcript: Kidney Cancer Survival Rate The kidney cancer survival rate depends on a number of different factors related to both the individual patient and to the kidney cancer itself. In estimating a kidney cancer survival rate, medical researchers must consider a general range of variables, including the type of cancer, the stage, the grade, and the location. There are also influential variables that are specific to each patient, including age, general health, and individual response to treatment. This said, medical researchers have been able to come up with general kidney cancer survival rate numbers. The statistics in this article focus on the most common type of cancer of the kidney, which is known as renal cell carcinoma. Calculations for the kidney cancer survival rate are expressed as a percentage of patients with a certain type of kidney cancer which has reached a certain stage Statistically, patients with kidney cancer of a certain type at a certain stage may generally expect to survive for at least a certain period of time after being diagnosed. Of course, as is the case with most studies, the kidney cancer survival rate is based on analysis of a large number of patients. It's impossible to accurately predict outcomes for every individual. The standard survival rate used for cancer of the kidney (and many other diseases) is a five-year interval. In other words, the percentage of kidney cancer patients will still be alive five years after their diagnosis. The percentage does not consider whether the patient still has kidney cancer, or whether he or she is completely in remission or free of symptoms. It only reports whether or not the patient is still alive. There are different ways to calculate kidney cancer statistics. The numbers below are based on a measure of the survival of kidney cancer patients in comparison to the general population. The time period in this study was 1995-2001. The overall kidney cancer survival rate for this period was 64.6 percent. Broken down by race and gender, the numbers were: 64.7 percent for Caucasian men 64.5 percent for Caucasian women 61.8 percent for African American men 65.9 percent for African American women. It's also important to consider how far the disease has progressed in calculating a survival rate. The degree of progress is known as the kidney cancer stage. 53 percent of kidney cancer cases are diagnosed while the cancer can only be found in the kidney. It has not spread to other parts of the body (metastasis). 20 percent of cases are discovered after cancer has spread to lymph nodes or directly beyond the primary area (known as the regional stage). 22 percent after has already metastasized in another organ or area of the body (the distant stage). Staging information was unknown for the remaining percentage. As you would expect, a higher percentage of patients whose kidney cancer was diagnosed in the earlier stages typically survived the longest. Other kidney cancer statistics include the following: 90 percent reached the five year survival mark when the cancer was localized in the kidney. 60 percent for regional 9.7 percent for distant 32.2 percent for unknown or undiagnosed stages.
Views: 8104 WS Westwood
Renal Cell Carcinoma: Past, Present, and Future
 
59:55
Information presented in this presentation is designed to increase knowledge about renal cell carcinoma (RCC). Information focuses on risk factors associated with RCC, the standard treatments for both localized and metastatic disease, and the future for RCC treatment. Learning Outcomes: • State the risk factors for kidney cancer, including the genetic syndromes associated with renal cell carcinoma. • Discuss the current status of adjuvant treatment for high-risk localized kidney cancer. • State the standard first- and second-line systemic therapies for metastatic kidney cancer. This lecture was presented as part of the Medical and Surgical Oncology Lecture Series.
Views: 870 UNC Cancer Network
Renal Cell Kidney Cancer with Lung and Bone Metastases
 
01:16
After one year of Issels Treatment Carol Gayle in her own words: March 17, 2008: "I've been on the Issels Program for a year. Every three months I have my CT scans and bone scans and every time I've gone since a year ago they have been improved. My tumors have decreased in size every time, there's no new cancer showing and I continue to be on the Issels Treatment and it's done very well for me." In March 2009 Carol reports to be in very good condition. The Issels Treatment is a comprehensive immunotherapy program that integrates the most effective state-of-the-art technologies, such as advanced cancer vaccines, and other safe and scientifically validated therapies. For more information on the Issels Treatment, please visit http://www.issels.com or call 1.888.447.7357.
Views: 9782 Issels Immunotherapy
Treating Advanced Renal Cell Carcinoma (RCC)
 
08:08
Take the kidney out, it’s all gone, you live happily ever after, to, yeah, this didn’t work so well. And it was very disappointing, of course. Nothing anybody can do about it. Move on from there. What’s next? ~Bruce Gowin, Advanced RCC Patient Immunotherapy for treatment of cancers has been around for a very long time. We actually used to use immunotherapy a lot to treat advanced kidney cancers until the targeted therapy era came, where we used pills to treat the kidney cancer instead. But now, there has been a re-emergence of immuno-onocology agents, next generation checkpoint inhibitors that actually rev up a patient’s immune system, so that the immune system attacks their own tumor. And, they’ve been able to extend survival, improve quality of life, and really revolutionize how we treat kidney cancer today. ~ Daniel Heng MD MPH FRCPC Clinical Associate Professor, University of Calgary Chair, Southern Alberta GU Tumor Group Staff Medical Oncologist, Tom Baker Cancer Center
Views: 200 editextreme
Recent Advances in Renal Cell Carcinoma
 
21:37
Dr. Erik P. Castle, MD, discusses the most recent advances in renal cell carcinoma treatment, especially in regards to individualized medicine, immunotherapy, robotics, partial nephrectomy, and other surgeries.
Renal Cell Carcinoma : : Causes, Diagnosis, Symptoms, Treatment, Prognosis
 
11:37
LIKE | COMMENT | SHARE | SUBSCRIBE For more info visit http://www.DiseasesAndTreatment.com/ ====================================== Renal Cell Carcinoma, RCC, Hypernephroma, Renal Adenocarcinoma, Renal Cancer, Kidney Cancer, What is Renal Cell Carcinoma, causes of Renal Cell Carcinoma, symptoms of Renal Cell Carcinoma, treatment of Renal Cell Carcinoma, diagnosis of Renal Cell Carcinoma, Complications of Renal Cell Carcinoma, risk factors of Renal Cell Carcinoma, prevention of Renal Cell Carcinoma, ======================================
Treatment Options in Renal Cell Carcinoma
 
08:39
The panelists, Robert Figlin, MD; Sandy Srinivas, MD; and Martin Voss, MD, comment on their thought processes when determining which treatment to use in renal cell carcinoma (RCC).
Views: 1446 OncLiveTV
3D Renal Cell Carcinoma
 
01:42
An interactive view of a renal cell carcinoma case seen on the Anatomage Table's interface in 3D. Tissues are removed and dissected layer-by-layer to examine the cancer up close. Additionally, you can view and interact with the case as a CT or MRI scan. The clinical library on the Table now has over 1,400 entries. Learn more at http://www.anatomage.com.
Views: 1302 Anatomage
New Drug Proves Effective For Renal Cell Cancer Patients
 
00:43
New research has identified a treatment for metastatic renal cell cancer that is more effective and better tolerated in the recovery of those patients. According to UPI online, the new drug known as nivolumab combined with ipilimumab revealed manageable safety, antitumor activity and favorable responses garnering potential long-term benefits across the board in patients with metastatic renal cell cancer. Annually there are 338,000 patients diagnosed with mRCC. The study, was published in the July edition of the Journal of Clinical Oncology. https://www.upi.com/Health_News/2017/07/26/Drug-combination-more-effective-in-metastatic-renal-cell-cancer/6101501081337/ http://www.wochit.com This video was produced by YT Wochit News using http://wochit.com
Views: 345 Wochit News
Killing Kidney Cancer With Ice - Percutaneous Renal Cryoablation Procedure  | Vlog 011
 
05:48
In today’s episode, Dr. Jon performs a percutaneous renal cryoablation on a patient with renal cell carcinoma, or cancer of the kidney. Have a question for us? Send us an email and we'll try and answer it in our new segment Q&A rounds! (Note that we won't be able to provide you with specific medical recommendations without taking you on as a patient): drjonanddrchris@glmirad.com Want to learn more about what services we offer? www.greatlakesmedicalimaging.com Facebook: https://www.facebook.com/glmirad/
Views: 994 Dr. Jon & Dr. Chris
KIDNEY CANCER EXPLAINED IN HINDI I MIC I PATIENT EDUCATION
 
03:47
Doctor Details : Dr.N.Ragavan KIDNEY CANCER EXPLAINED IN HINDI I MIC I PATIENT EDUCATION Urologist The aim of Medical Information Clear videos is to create a public awareness of various diseases. In our channel, we provide information about various diseases, and it's Causes, symptoms, how to overcome from it are clearly explained by our beloved doctors in their native languages. We choose doctors based on their field of expertise and reputation. If any doctors wish to join in our channel, Please contact us through below mail id Email : mic@nvronlifescience.com info@nvronlifescience.com Video By Medical Information Clear ( Nvron Life Science Limited )
6 Subtle Signs Of Kidney Cancer That You Need To Know
 
03:39
Kidney cancer doesn't get much of an attention unlike those of breast, skin, or prostate cancer. Kidney cancer refers to renal cell carcinoma or RCC. This makes up about 85% of all kidney cancer. RCC throws up as a tumour in the lining of one of the kidney tubules. Humans have two kidneys, which filter the blood of waste and toxins. Kidneys also balance the chemical composition of the blood and also manage its heath and urine production. The kidneys also produce hormones that help digest food. This encourages the bone marrow to produce red blood cells. The symptoms of kidney cancer appear in places like your urine tract or lower back. They have more to do with kidney function and tumour growth. Its symptoms do not appear until the later stages or until the tumour has grown large. It is only accidentally found during routine imaging tests. This video deals with the top warning signs that your body produces when the kidneys are in trouble. Continue watching to know about these subtle symptoms of kidney cancer. 1. Blood In Urine: This is one of the common symptoms of advanced stage RCC. Immediate medical attention is required in this case. 2. Back/Side Pain: Pain or pressure in the back or side is also a symptom of kidney cancer. The kidney mass might have become large and exerting pressure on the sides, thus giving you pain. 3. Fatigue: Persistent fatigue or weariness is actually a sign of kidney cancer. It is better to consult a doctor in order to make sure what is the source of weariness. 4. Weight Loss: Kidneys play an important role in metabolism and digestion. The ability to break down and absorb food will be hit if your kidneys are affected. Hence, weight loss is a common symptom of kidney cancer 5. Blood-related Issues: Kidney tumours can lead to anaemia, electrolyte or calcium imbalances or other blood-related issues. Hence, medical attention is required in these cases. 6. Diagnosis: If the doctors are able to detect kidney cancer, then they may remove the mass of infected cells through a procedure called nephrectomy. Here, the cancerous part alone is removed and the normal cells are left as they are. Even doctors may find it difficult to diagnose kidney cancer, hence it is better to go for regular body checks and scan to know of the cancer type and stage. #SignsOfKidneyCancer #KidneyCancer #RenalCancer #Kidney #Cancer Video URL : https://youtu.be/0-rEV044x_M
Views: 42102 Health Care Tips
Renal Cell Carcinoma Patient Testimonial at Cleveland Clinic
 
03:04
Learn more about Stewart Brown, a Cleveland Clinic patient who had successful minimally invasive kidney cancer surgery for renal cell carcinoma performed by Jihad Kaouk, MD, Director of Laparoscopic and Robotic Surgery at the Glickman Urological and Kidney Institute. Learn more about kidney cancer treatment at Cleveland Clinic by visiting http://www.clevelandclinic.org/kidneycancerguide. Stay connected to Cleveland Clinic: ➨ Visit Cleveland Clinic: http://bit.ly/XlxDfr ➨ Visit Health Hub from Cleveland Clinic: http://bit.ly/VBQ3nW ➨ Subscribe to our YouTube Channel: http://bit.ly/W0bJ0y ➨ Like Cleveland Clinic on Facebook: http://on.fb.me/WMFkul ➨ Follow Cleveland Clinic on Twitter: http://bit.ly/Uua1Gs ➨ Follow Cleveland Clinic on Pinterest: http://bit.ly/11QqS3A
Views: 8928 Cleveland Clinic
Supportive and Palliative Care for Patients With Renal Cell Carcinoma
 
05:07
Moderator Robert A. Figlin, MD, and panelists Daniel Heng, MD, MPH, Brian I. Rini, MD, FACP, Charles A. Henderson, MD, and Janice P. Dutcher, MD, discuss supportive care and palliative care interventions for patients with RCC. For more from this discussion, visit http://www.onclive.com/peer-exchange/rcc-cases
Views: 200 OncLiveTV
Papillary renal cell carcinoma
 
01:26
Patient with hematuria. MR images demonstrate a T2 hypointense mass arising from the kidney. While enhancement is difficult to perceive on the standard post-gadolinium images, the subtraction images demonstrate subtle nodular enhancement along the posterior margin of the mass, increasing over the venous and delayed images. This was found to be a papillary renal cell carcinoma.
Views: 1129 CTisus
Take Out That Kidney! - My Battle With Stage IV Renal Cell Cancer
 
02:44
In June, 2017, I collapsed at the park and was taken to a local hospital where specialists found a cancerous tumor on my kidney. The stage IV cancer has also spread to my lungs and spine. Medical professionals are currently using every possible option to treat this terrible disease. At this time, I am scheduled to undergo radical nephrectomy (complete removal), of my right kidney. I will fight with everything I have to beat this thing. Thank you for the love and support and to others who are facing a similar battle..may you be blessed in your fight as well. Let's kick cancer's ass! - Clay - https://www.gofundme.com/medical-fund-for-clay-mullins
Views: 693 Living With Cancer
Novel Therapies in Renal Cell Carcinoma
 
09:36
Sumanta Kumar Pal, MD, Brian Rini, MD, and Daniel J. George, MD, discuss key clinical trials focused on the treatment of patients with renal cell carcinoma. To view more from this discussion, visit http://www.onclive.com/peer-exchange/rcc-treatment
Views: 283 OncLiveTV
Outcomes for patients with locally advanced renal cell carcinoma Christopher G. Wood, M.D., UT
 
27:59
Outcomes for patients with locally advanced renal cell carcinoma Christopher G. Wood, M.D., UT MD Anderson Cancer Center
Views: 3963 Kidney Cancer
Easy way to remember TNM Staging of Renal Cell Carcinoma with Visual mnemonic
 
12:36
You will never forget TNM staging of the kidney with this method.
Views: 1342 MED Tutorials
5 Common Signs of Kidney Cancer
 
10:50
Hi, I am Qila. On this occation, I will talk about 5 Common Signs of Kidney Cancer that you should to know. Thankfully, many of you are well versed in watching "5 Common Signs of Kidney Cancer". Knowing the early 5 Common Signs of Kidney Cancer can help you receive the best treatment before the disease becomes serious or even life threatening. Kidney cancer, also called Renal Cell Carcinoma (RCC) is one of the 10 most common cancers in both men and women. But the signs don’t often appear until later stages or until the tumor is large. The signs of kidney cancer appear in places like your urine or lower back. Most likely they have to do with your kidney function and tumor growth. And Here are, 5 Common Signs of Kidney Cancer that you should to Know; 1. You have Hematuria. 2. Persistent Lower Back Pain. 3. Abdominal Lump. 4. Fatigue. 5. Swollen Legs. Well, If you experience any of the following 5 Common Signs of Kidney Cancer that I mentioned above, make an appointment with your health care provider as soon as possible to make sure that your kidney are in good condition. Most of the Signs of kidney cancer can be the result of other less serious problems. But these signs should not be ignored especially if you have more than one of them. With an early diagnosis, you can increase your chance of successful treatment and improve the long-term outlook of your condition. Thank you for watching "5 Common Signs of Kidney Cancer". Early Detection Could Save Your Life Longer. SUBSCRIBE for more videos. Hope you feel better
Kidney Cancer | Dr. Tony Talebi discusses the Treatment of Stage 4 Metastatic Renal Cell Carcinoma
 
26:06
Dr. Tony Talebi discusses the management of stage 4, metastatic kidney cancer with Dr. Merchan. For further information visit http://www.HemOnc101.com. Dr. Talebi's practice, Miami Hematology and Oncology Associates is located at 151 NW 11th street, Suite W303. Homestead, Fl 33030. Tel 786-504-3084 Treatment of metastatic stage 4 kidney cancer Kidney cancer or Renal cell carcinomas (RCCs), which originate within the renal cortex, constitute 80 to 85 percent of primary kidney (renal) neoplasms. Transitional cell carcinomas of the renal pelvis are the next most common (approximately 8 percent). Other parenchymal epithelial tumors, such as oncocytomas, collecting duct tumors, and renal sarcomas, are rare. Patients with kidney cancer or RCC can present with a range of symptoms; unfortunately, many patients are asymptomatic until the disease is advanced. At presentation, approximately 25 percent of individuals either have distant metastases or advanced locoregional disease. Patients with localized disease can present with a wide array of symptoms and/or laboratory abnormalities, or they may be diagnosed incidentally. The most common presenting symptoms were blood in the urine (hematuria), abdominal mass, pain, and weight loss. For patients with isolated, solid kidney masses, resection with either a partial or complete nephrectomy is preferred to biopsy because it provides both the diagnosis and definitive treatment. Here, Dr. Tony Talebi discusses the treatment of metastatic stage 4 kidney cancer (RCC) with Dr. Jaime Merchan, an assistant professor of medicine at the University of Miami Sylvester Comprehensive Cancer Center including symptoms, diagnosis, staging, surgery, RFA, high dose IL-2, and chemotherapy treatment for kidney cancer or renal cell carcinoma. Dr. Jaime Merchan credentials: Certifications American Board of Internal Med-Hematology American Board of Internal Med-Medical Oncology Specialties Internal Medicine Hematology/Oncology - Internal Medicine Roles Assistant Professor of Clinical Medicine Clinical Interests Gastrointestinal and Genitourinary Malignancies Research Interests Tumor Angiogenesis, vascular targeting, experimental therapeutics Education 2003 Masters Harvard Medical School and Massachusetts Institute of Technology 1998 Fellowship Beth Israel Deaconess Med Ctr/Harvard Medical School 1997 Chief Resident U of Miami/VA Medical Center 1995 Residency U of Miami/Jackson Memorial Med Center 1994 Internship U of Miami/Jackson Memorial Med Ctr 1992 M.D. Universidad Catolica de Santiago de Guayaquil
Views: 5698 Tony Talebi
Paula Edwards discusses her advanced kidney cancer (Renal cell carcinoma)
 
55:16
Paula Edwards came in to give her account of kidney (renal) cancer, which was diagnosed in 2012. She discusses her diagnosis, kidney surgery, chemotherapy and the treatment side effects. Paula also discusses the impact of losing her mother and aunt to cancer. She gives mentions the importance about emotional support from family and work colleagues. Story by: Paula Edwards Diagnosis: Kidney cancer Interviewer: Alex J Mitchell Music: Emma O'Brien Resolution: 720p (1280x720) Permissions: Email coping.with.cancer.uk@gmail.com
Views: 826 MyCancerStory
Treatment of Metastatic Non-Clear Cell Renal Cell Carcinoma
 
06:53
In this segment, panelists discuss the treatment of patients with metastatic non-clear cell renal cell carcinoma, which is a histologic subtype that has largely been excluded from clinical trials exploring approved therapies. For more from this discussion, visit http://www.onclive.com/peer-exchange/rcc-treatment
Views: 432 OncLiveTV
Investigating Immunotherapy Treatment in Renal Cell Carcinoma
 
01:25
Charles G. Drake, MD, PhD, professor of medical oncology at New York Presbyterian/Columbia University Medical Center, discusses his thoughts on whether sunitinib would be more successful as a treatment for patients with renal cell carcinoma if used in the neoadjuvant setting. He debates whether immunotherapies or neoadjuvant therapies would be more useful. Sunitinib has been the standard of care in the frontline setting of kidney cancer, but it has increasingly become less common. For patients with intermediate- and high-risk disease, many oncologists have been using combination immunotherapy with anti-PD-1 and anti-C24, Drake explains. Preclinical and clinical data has also supported the idea of immunotherapy treatments before surgery. Drake says, a recent report in the New England Journal of Medicine showed neoadjuvant immunotherapy was more efficacious in lung cancer. However, this has not been suggested yet for kidney cancer, but an ECOG trial is currently investigating nivolumab monotherapy in the neoadjuvant setting. For more resources and information regarding anticancer targeted therapies in renal cell carcinoma or other kidney cancers: http://www.targetedonc.com/resource-center/RCC
Views: 109 Targeted Oncology
Two New Drugs for Renal Cell Cancer
 
04:57
Latest news on Renal Cell Cancer, a form of kidney cancer and colonoscopy screening for colon cancer
Views: 11466 OncologyPodCasting
First-Line Considerations in Metastatic Renal Cell Carcinoma
 
05:50
Bernard Escudier, MD, and Susanne Osanto, MD, explain their approaches to initiating treatment in patients with metastatic renal cell carcinoma.
Views: 128 OncLiveTV
Dr. Bernard Escudier on Patients Preferring Pazopanib for Metastatic Renal Cell Carcinoma
 
01:46
Bernard J. Escudier, MD, a physician at the Institut Gustave Roussy, Villejuif, France, discusses the PISCES study, which sought to find the patient preferred first-line therapy for metastatic renal cell carcinoma (mRCC) by comparing patient-reported preferences for sunitinib (Sutent) and pazopanib (Votrient). Find out more at http://www.onclive.com/onclive-tv/Dr-Escudier-on-Patients-Preferring-Pazopanib-for-mRCC
Views: 1113 OncLiveTV
Kidney Cancer Treatment Options
 
04:16
Transcript: Kidney Cancer Treatment Options Kidney cancer treatment options usually include five types of therapies. Others are currently being tested in clinical trials. Such trials are research studies whose goal is to improve on current kidney cancer treatment options or develop new ones. The five standard kidney cancer treatment options currently in use include surgery, radiation, chemotherapy, biologic therapy and targeted therapy. Surgery - This is done to remove part or all of the kidney. It is often used to treat the kind of kidney cancer known as renal cell carcinoma, and is known as a nephrectomy, or kidney removal surgery. It is the most common type of kidney cancer treatment. There are several kinds of nephrectomies. A partial nephrectomy is done to remove the cancer within the kidney and possibly some of the tissue around it. This leaves part of the kidney in place, and it continues to function. It's possible for an individual to live if part of one kidney is still working. A simple nephrectomy is a procedure in which an entire kidney is removed. A radical nephrectomy involves removing an entire kidney, the adrenal gland, surrounding tissue, and, in many cases, lymph nodes that are located nearby. Even if all the cancer appears to have been removed through a nephrectomy, the doctor may still recommend other forms of kidney cancer treatment, like chemotherapy or radiation in case any cancer cells still remain. This is known as adjuvant therapy, and it lowers the risk that kidney cancer will return. Radiation therapy - This is another kidney cancer treatment. It employs high-energy x-rays or other types of radiation to kill cancer cells or keep them from growing. Two types of radiation therapy are commonly used today. External radiation therapy focuses radiation from a machine outside the body on the cancerous area. Internal radiation uses radioactive substances that are placed directly into or near the cancer. The doctor will choose the type of radiation based on the stage the cancer has reached. Chemotherapy - Everyone knows what chemotherapy is. As with other forms of cancer, chemicals that kill cancer cells are introduced into the body. The goal is to stop cancerous cells from dividing. There are a number of different ways to administer chemotherapy for renal cell carcinoma or kidney cancer. Once again, the doctor decides based on the type of kidney cancer the patients has and the stage it has reached. Biologic therapy - This type of uses the patient's own immune system. Substances made by the body or made in a laboratory assist the body's natural defenses in battling the cancer cells. This type of kidney cancer treatment is also known as biotherapy or immunotherapy. Targeted therapy - This type uses medications or other agents to identify and attack specific cancer cells without harming normal cells. This treatment is often done to treat advanced renal cell cancer. It uses antiangiogenic agents, which keep blood vessels from forming in a tumor. Without a sufficient supply of blood, the tumor will either stop growing or shrink. A treatment known as arterial embolization may be also be used to shrink the tumor when surgery isn't possible. In this procedure, the surgeon makes a small incision and places a catheter into the main blood vessel that flows to the kidney. Tiny pieces of a special gelatin sponge are then fed into the blood vessel. This blocks the blood flow and "starves" the cancer cells of oxygen and other substances they need to grow. Cancer is one of the most serious kidney problems. If kidney cancer treatment is not successful and cancer destroys both kidneys, there are only two options for survival: years of kidney dialysis, or a kidney transplant.
Views: 4795 WS Westwood
Histopathology Kidney-- Renal cell carcinoma
 
03:14
Histopathology Kidney-- Renal cell carcinoma
Views: 12634 WashingtonDeceit
Recent Advances in Metastatic Kidney Cancer
 
04:16
Toni Choueiri, MD, offers a historical perspective on the evolving treatment landscape in advanced renal cell carcinoma, including the expanded approval of cabozantinib in the frontline setting. For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Views: 161 Targeted Oncology
Latest in adjuvant therapy for renal cell carcinoma
 
11:33
Dr Haas speaks with ecancer at the 2018 ASCO Genitourinary Cancers Symposium about the latest research into adjuvant therapy for renal cell carcinoma. She highlights three recent trials of note; - The ASSURE trial - The ProtecT trial - The S-TRAC trial She goes on to highlight the immune checkpoint inhibitor, PROSPER trial, looking at the use of perioperative nivolumab vs. observation in patients with localised renal cell carcinoma undergoing nephrectomy. Finally she discusses the recent FDA approval of sunitinib for adjuvant treatment for renal cell carcinoma.
Views: 88 ecancer
Pazopanib and Sunitinib in Renal Cell Carcinoma
 
05:40
Robert Figlin, MD, and Nizar Tannir, MD, FACP, examine data comparing tyrosine kinase inhibitors (TKIs), pazopanib with sunitinib, in renal cell carcinoma (RCC).
Views: 1980 OncLiveTV